Defining the Molecular Risk in Israeli Patients With Secondary Compared to Primary Myelofibrosis

Conditions:   Myelofibrosis, Primary;   Myelofibrosis, Post PV;   Myelofibrosis, Post ET Intervention:   Other: Molecular analysis Sponsor:   Assaf-Harofeh Medical Center Recruiting

Source: ClinicalTrials.gov - January 18, 2018 Category: Research Source Type: clinical trials